From: Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
Best overall responsea
Planned dose level, mg/m2
Investigator’s response
Response review meeting (expert)
Final evaluation
8.4
PR
NC
10
NCb
NCc
NC c
12